相关实验视频
Updated: May 2, 2026

07:48
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
12.4K
膀癌治疗的新方法:纳米颗粒作为药物输送系统
Xinming Zhao1, Xiaochen Qi1, Dequan Liu1
1Department of Urology, The First Affiliated Hospital of Dalian Medical University, Dalian, 116011, People's Republic of China.
International journal of nanomedicine
|December 23, 2024
概括
纳米颗粒为膀癌治疗提供了一种有前途的方法,通过改善药物输送和使组合疗法成为可能. 本综述探讨了它们在增强非手术治疗和克服当前挑战方面的作用.
科学领域:
- 在瘤学瘤学.
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
背景情况:
- 膀癌是一种常见的恶性瘤,由于复发率高和晚期的不良结果,它带来了重大挑战.
- 目前针对非侵入性和侵入性膀癌的治疗方法面临局限性,特别是在高度和晚期疾病中.
- 纳米粒子表现出有利的特性,如稳定性,用于药物加载的多孔结构,以及组合治疗的潜力.
研究的目的:
- 审查纳米粒子应用在非手术性膀癌治疗中的最新进展.
- 为了检查基于纳米粒子的输送,治疗疗效和膀癌中的毒性.
- 确定纳米颗粒在膀癌治疗中的临床应用的挑战和未来方向.
主要方法:
- 关于基于纳米粒子的膀癌治疗的最新进展的文献综述.
- 对纳米粒子属性的分析与药物输送和组合疗法相关.
- 在临床前和临床研究中评估纳米颗粒的治疗疗效和毒性概况.
主要成果:
- 纳米粒子增强药物的生物可用性,向性和控制释放性,用于膀癌治疗.
- 他们促进组合疗法,整合化疗,免疫疗法,基因疗法和光疗.
- 纳米颗粒显示出降低与传统治疗相关的局部和全身毒性的潜力.
结论:
- 纳米粒子代表了一种新的药物输送系统,具有非手术性膀癌治疗的巨大潜力.
- 它们独特的特性使其有效性提高,毒性降低,提供新的治疗途径.
- 需要进一步的研究和临床翻译,以克服纳米粒子为基础的膀癌症治疗的挑战.
相关概念视频
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164

